KIP — Kolinpharma SpA Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
- €15.98m
- €15.21m
- €14.06m
Brief: KOLINPHARMA H1 Net Result Turns To Profit Of EUR 0.4 Mln, Sees 2024 Revenue Between EUR 18-20 Mln
Brief: Kolinpharma To Set Up Unit In Switzerland
Brief: Kolinpharma Launches Food Supplement XINPROX®
Brief: Kolinpharma H1 Revenue Up 110% At About EUR 5.1 Mln
Brief: Kolinpharma Launches Certified Food Supplement Doltendix
Brief: Kolinpharma Signs Deal With Apharm For Exclusive Distribution In Italy Of Medical Device Dolatrox® Hcc
Italy - Factors to watch on May 19
Italy - Factors to watch on April 14
Brief: Kolinpharma FY Net Profit Up At EUR 642,372
Brief: Kolinpharma Obtains License In Italy For Miledix
Brief: Kolinpharma Obtains Financing From Unicredit For EUR 800,000
Brief: Kolinpharma Obtains Patent For Food Supplement Milesax In U.S.
Brief: Kolinpharma H1 Net Loss Narrows To EUR 127,668
Brief: Kolinpharma Obtains EUR 1 Mln Loan
Brief: Kolinpharma Launches Ivuxur Tablets Food Supplement
Brief: Kolinpharma Obtains EUR 3 Mln Loan Under Italy's Guarantee Scheme SACE
Brief: Kolinpharma Launches KIP KIT Box
Brief: Kolinpharma Signs Partnership Deal With Università Degli Studi Di Milano
Brief: Kolinpharma Top Shareholder Sells 12.20% Stake